The PERSISTENT trial: A prospective randomized trial comparing insulin lispro protamine suspension to insulin glargine in patients with type 2 diabetes on anti-hyperglycemic medications.
Phase of Trial: Phase III
Latest Information Update: 04 Jun 2015
At a glance
- Drugs Insulin neutral protamine lispro (Primary) ; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms PERSISTENT
- Sponsors Eli Lilly
- 31 Aug 2018 Biomarkers information updated
- 23 Jun 2012 Planned number of patients changed from 482 to 511 as reported by European Clinical Trials Database.
- 01 Oct 2010 Primary endpoint 'Proportion of glycosylated haemoglobin' has been met according to results published in Diabetes, Obesity and Metabolism.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History